Regression of choroidal metastases from breast carcinoma using aromatase inhibitors [7]

British Journal of Ophthalmology

Volumn 89, Issue 6, 2005, Pages 776-777

  Manquez, Maria E ^a,b   Shields, C L ^a   Karatza, E C ^a   Shields, J A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; ESTROGEN RECEPTOR; LETROZOLE; TAMOXIFEN; VOROZOLE;

AGED; BREAST CARCINOMA; CASE REPORT; CHOROID CANCER; DRUG MECHANISM; FEMALE; HUMAN; IMAGE ANALYSIS; LETTER; LYMPH NODE METASTASIS; MASTECTOMY; METASTASIS; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; VISUAL ACUITY;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST NEOPLASMS; CHOROID NEOPLASMS; FEMALE; HUMANS; NITRILES; TRIAZOLES;

EID: 20344382283     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.061127     Document Type: Letter

References (9)

1. Feig BW, Berger DH, Fuhrman GM. In: Breast cancer. The MD Andersen surgical oncology handbook. Philadelphia: Lippincott Williams and Wilkins, 2003:14.
2. Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med 1998;339:1609-18.
3. Smith IE, Dowsett M. Aromatase inhibitors in breast cancer. N Engl J Med 2003;348:2431-42.
4. Shields JA, Shields CL In: Metastatic tumor to the uvea and retina. Intraocular tumors. A text and atlas. Philadelphia: WB Saunders, 1992:278-320.
5. Shields CL, Shields JA, Gross N, et al. Survey of 520 eyes with uveal metastases. Ophthalmology 1997;104:1265-76.
6. Shields CL. Plaque radiotherapy for the management of uveal metastasis. Curr Opin Ophthalmol 1998;9:31-7.
7. Demirci H, Shields CL, Chao AN, et al. Uveal metastasis from breast cancer in 264 patients. Ophthalmology 2003;136:264-71.
8. ATAC (Arimiaex, Tamoxifen Alone or in Combination) Trialists' Group. Anastrozole alone or in combination with tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial. Lancet 2002;359:2131-9.
9. Mouridsen H, Gershanovich M, Sun Y, et al. Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol 2001;19:2590-606.